AI
MIRM icon

Atom Investors’s Mirum Pharmaceuticals MIRM Stock Holding History

Atom Investors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,268
Closed -$522K – 550
2024
Q2 		$522K Sell
15,268
-162
-1% -$4.25K 0.05% 326
2024
Q1 		$388K Buy
15,430
+4,977
+48% +$137K 0.05% 372
2023
Q4 		$309K Sell
10,453
-2,689
-20% -$81.4K 0.05% 352
2023
Q3 		$415K Buy
13,142
+4,518
+52% +$124K 0.09% 261
2023
Q2 		$223K Buy
+8,624
New +$229K 0.08% 229

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Atom Investors's MIRM Position: Q3 2024 in Review

Atom Investors sold out of Mirum Pharmaceuticals (MIRM) in Q3 2024, closing a stake of 15,268 shares — an estimated $522K sold.

Atom Investors first reported a position in MIRM in Q2 2023 and held it in 5 quarters. The position peaked at $522K in Q2 2024. 178 funds tracked by Wall St. Rank hold MIRM as of Q3 2024.

  • Atom Investors reported no remaining Mirum Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Atom Investors sold 15,268 Mirum Pharmaceuticals shares in Q3 2024, an estimated $522K.
  • Atom Investors first reported a position in Mirum Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Atom Investors's Mirum Pharmaceuticals position peaked at $522K in Q2 2024.
  • 178 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2024.

Based on Atom Investors's 13F filing for Q3 2024, filed 14 Nov 2024.